.Nature Medication, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- drug conjugate (ADC) tisotumab vedotin resulted in improved progression-free as well as overall survival, triggering FDA approval as well as a brand new treatment choice for clients.